A major study led by Macquarie University has examined the deep environmental, technological and societal challenges ...

This new technology could one day significantly expand the market for gene-editing biotechs.

13-year-old Rickey Buggs became the first commercial patient to receive a gene-editing treatment for sickle cell disease at ...

Cadmium (Cd) contamination poses a serious threat to global food safety. As a toxic and carcinogenic heavy metal, cadmium can ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.

Add Yahoo as a preferred source to see more of our stories on Google. A sperm being injected into an egg cell in a lab dish. A preprint describing genetically edited human embryos is raising concerns ...

A novel prime editing tool has unraveled some of the mysteries of fungi and identified compounds with promising anti-cancer ...

Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...

Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.